UBS Oncology Impact Fund - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

UBS Oncology Impact Fund

investment firm

Summary
Investments
Exits

About

UBS Oncology Impact Fund

Highlights

Lead Investments

Details

Operating Status: Active

Investments

Number of Investments

Number of Lead Investments

5

1

UBS Oncology Impact Fund has made 5 investments. Their most recent investment was on Sep 4, 2019, when Repare Therapeutics raised $82.50M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Sep 4, 2019 Repare Therapeutics	Series B	$82.50M	Biotechnology	—
Aug 21, 2019 Oncorus	Series B	$79.50M	Biotechnology	—
May 13, 2019 ElevateBio	Series A	$150M	Biotechnology	Yes
Oct 3, 2017 Cullinan Oncology	Series A	$150M	Biopharma	—
Jun 22, 2017 Repare Therapeutics	Series A	$68M	Biotechnology	—

Exits

UBS Oncology Impact Fund has had 3 exits. UBS Oncology Impact Fund most notable exits include Cullinan Oncology , Oncorus

Date	Company Name	Exit Type	Industry
Jan 7, 2021	Cullinan Oncology	IPO	Biopharma	Detail
Oct 1, 2020	Oncorus	IPO	Biotechnology	Detail
Jun 18, 2020	Repare Therapeutics	IPO	Biotechnology	Detail